Polymorphisms of mouse apolipoprotein A-II: Seven alleles found among 41 inbred strains of mice

Amyloid

Volumn 10, Issue 4, 2003, Pages 207-214

  Kitagawa, Kaori ^a   Wang, Jing ^b   Mastushita, Takatoshi ^c   Kogishi, Kumiko ^c   Hosokawa, Masanori ^d   Fu, Xiaoying ^e   Guo, Zhanjun ^e   Mori, Masayuki ^e   Higuchi, Keiichi ^e  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KYOTO UNIVERSITY   (Japan)

^d INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^e SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid protein; Apolipoprotein A II; Cholesterol; Mouse strains; Polymorphism; Sequence.

Indexed keywords

AMYLOID; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENE FREQUENCY; INBRED STRAIN; MOUSE; MOUSE STRAIN; MUS MUSCULUS DOMESTICUS; MUS MUSCULUS MOLOSSINUS; MUS MUSCULUS MUSCULUS; MUS SPRETUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; STRAIN DIFFERENCE;

EID: 1642463017     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120309041737     Document Type: Article

References (50)

1. Barbaras R, Puchois P, Fruchart JC and Ailhaud G (1987). Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpAI:A-II particles. Biochem Biophys Res Comm 142, 63-69
2. Matsunaga T, Hiasa Y, Yanagi H, Maeda T, Hattori N, Yamakawa K, Yamanouchi Y, Tanaka I, Obara T and Hamaguchi H (1991). Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc Natl Acad Sci USA 88, 2793-2797
3. Pieters MN, Castro GG, Schouten D, Duchateau P, Fruchart JC and Van Berkel TJ (1993). Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters. Biochem J 292, 819-823
4. Hedrick CC, Castellani LW, Warden CH, Puppione DL and Lusis AJ (1993). Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J Biol Chem 268, 20676-20682
5. Mehrabian M, Qiao JH, Hyman R, Ruddle D, Laughton C and Lusis AJ (1993). Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscl Thromb 13, 1-10
6. Schultz JR, Verstuyft JG, Gong E, Nichols AV and Rubin EM (1993). Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365, 762-764
7. Warden CH, Daluiski A, Bu X, Purcell-Huynh DA, De Meester C, Shieh BH, Puppione DL, Gray RM, Reaven GM, Chen YD, Rotter JI and Lusis AJ (1993). Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. Proc Natl Acad Sci USA 90, 10886-10890
8. Weng W and Breslow JL ( 1996). Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci USA 93, 14788-14794
9. Purcell-Huynh DA, Weinreb A, Castellani LW, Mehrabian M, Doolittle MH and Lusis AJ (1995). Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach. J Clin Invest 96, 1845-1858
10. Wang J, Kitagawa K, Kitado H, Kogishi K, Matsushita T, Hosokawa M and Higuchi K (1997). Regulation of the metabolism of plasma lipoproteins by apolipoprotein A-II. Biochim Biophys Acta 1345, 248-258
11. Warden CH, Hedrick CC, Qiao J-H, Castellani LW and Lusis AJ (1993). Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261, 469-472
12. Yokoyama S (1998). Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta 1392, 1-15
13. Hamilton KK, Zhao J and Sims PJ (1993). Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9. J Biol Chem 268, 3632-3638
14. Handwerger S, Quarfordt S, Barrett J and Harman I (1987). Apolipoproteins AI, AII, and CI stimulate placental lactogen release from human placental tissue. A novel action of high density lipoprotein apolipoproteins. J Clin Invest 79, 625-628
15. Motizuki M, Itoh T, Satoh T, Yokota S, Yamada M, Shimamura S, Samejima T and Tsurugi K (1999). Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II. Biochem J 342, 215-221
16. Sipe JD (1992). Amyloidosis. Annu Rev Biochem 61, 947-975
17. Westermark P (1998). The pathogenesis of amyloidosis. Understanding general principles. Am J Path 152, 1125-1127
18. SAM is an apoA-II apolipoprotein of mouse high density lipoprotein. J Biol Chem 261: 12834-12840
19. SAM) and human apolipoprotein A-II. FEBS Lett 203, 149-152
20. Takeshita S, Hosokawa M, Irino M, Higuchi, Shimizu K, Yasuhira K and Takeda T (1982). Spontaneous age-associated amyloidosis in Senescence- Accelerated Mouse (SAM). Mech Ageing Dev 20, 13-23
21. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K and Takeda T (1983). Systemic senile amyloid in Senescence- Accelerated Mice: A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 48, 231-240
22. SAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Arch B Cell Pathol 60, 231-239
23. Chai CK (1978). Spontaneous amyloidosis in LLC mice. Am J Pathol 90, 381-391.
24. Gruys E, Tooten PC and Kuijpers MH (1996). Lung, ileum and heart are predilection sites for AApoAII amyloid deposition in CD-I Swiss mice used for toxicity studies. Pulmonary amyloid indicates AApoAII. Lab Anim 30, 28-34
25. HogenEsch H, Niewold TA, Higuchi K, Tooten PC, Gruys E and Radl J (1993). Gastrointestinal AAPOAII and systemic AA-amyloidosis in aged C57BL/Ka mice. Amyloid-type dependent effect of long-term immunosuppressive treatment. Virchows Arch B Cell Pathol Incl Mol Pathol 64, 37-43
26. Scheinberg MA, Cathcart ES, Eastcott JW, Skinner M, Benson M and Shirahama T (1976). The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects. Lab Invest 35, 47-54
27. Shimizu K, Morita H, Niwa T, MaedaK, Shibata M, Higuchi K and Takeda T (1993). Spontaneous amyloidosis in senile NSY mice. Acta Pathol Jpn 43, 215-221
28. Staats J (1985). Standardized nomenclature for inbred strains of mice: eighth listing. Cancer Res 45, 945-977
29. West WT and Murphy ED ( 1965). Sequence of deposition of amyloid in strain A mice and relationship to renal disease. J Natl Cancer Inst 35, 167-174
30. Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M and Takeda T (1991). Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Biochem J 279, 427-433
31. Higuchi K, Hosokawa M and Takeda T (1999). Senescence-accelerated mouse. Methods Enzymol 309, 674-686
32. Higuchi K, Naiki H, Kitagawa K, Kitado H, Kogishi K, Matsushita T and Takeda T (1995). The apoA-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic apoA-II. Lab Invest 72, 75-82
33. Higuchi K, Wang J, Kitagawa K, Matsushita T, Kogishi K, Naiki H, Kitado H and Hosokawa M (1996). Accelerated senile amyloidosis induced by amyloidogenic ApoA-II gene shortens the life span of mice but does not accelerate the rate of senescence. J Gerontol A Biol Sci Med Sci 51, B295-302
34. Naiki H, Higuchi K, Shimada A, Takeda T and Nakakuki K (1993). Genetic analysis of murine senile amyloidosis. Lab Invest 68, 332-337
35. Benson MD, Liepnieks JJ, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B and Kluve-Beckerman B (2001). A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein All gene. Genomics 72, 272-277
36. Doolittle DP, Davisson MT, Guidi JN and Green MC (1996). Catalog of mutant genes and polymorphic loci. In Lyon MF, Rasten SS, Brown DM (eds.) Genetic Variants and Strains of the Laboratory Mouse, 3rd ed, pp. 17-854. (Oxford University Press, Oxford UK)
37. Higuchi K, Kogishi K, Wang J, Xia C, Chiba T, Matsuchita T, Hoshii Y, Kawano H, Ishihara T, Yokota T and Hosokawa M (1998). Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 78, 1535-1542
38. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M and Higuchi K (2001) Transmission of mouse senile amyloidosis. Lab Invest 81, 493-499
39. Ando Y, Tanaka Y, Ueyama H, Sakashita N, Yonehara T, Higuchi K and Araki S (1993). Low plasma apolipoprotein All levels in human and mouse amyloidosis with mutant transthyretin (Met-30) gene. Ann Neurol 33, 101-103
40. Xing Y and Higuchi K (2002) Amyloid fibril proteins. Mech Ageing Dev 123, 1625-1636
41. Wang J, Matsushita T, Kogishi K, Xia C, Ohta A, Chiba T, Nakamura A, Kondo H, Mori M, Hosokawa M and Higuchi K (2000). Wild type ApoA-II gene does not rescue senescence-accelerated mouse (SAMP1) from short life span and accelerated mortality. J Gerontol A Biol Sci Med Sci 55, B432-B439
42. Guo Z, Toichi E, Hosono M, Hosokawa T, Hosokawa M, Higuchi K and Mori M (2000). Genetic analysis of lifespan in hybrid progeny derived from the SAMP1 mouse strain with accelerated senescence. Mech Ageing Dev 118, 35-44
43. Castellani LW, Goto AM and Lusisl A (2001). Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 50, 643-651
44. Soto C, Sigurdsson EM, Morelli L, AsokKumar R, Castaño EM and Frangione B (1998). β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 4, 822-826
45. Osherovich LZ and Weissman JS (2001). Multiple Gln/Asnrich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106, 183-194
46. Chiba T, Kogishi K, Wang J, Xia C, Matsushita T, Miyazaki J, Saito I, Hosokawa M and Higuchi K (1999) Mouse senile amyloid deposition is suppressed by adenovirus-mediated overexpression of amyloid-resistant apolipoprotein A-II. Am J Pathol 155, 1319-1326
47. Chai CK and Lerner C (1985). The inheritance of spontaneous amyloidosis development in mice: a model for hereditary threshold metabolic disorders. Am J Med Genet 22, 49-58
48. Umezawa M, Tatematsu K, Korenaga T, Fu X, Matushita T, Okuyama H, Hosokawa M, Takeda T and Higuchi K. (2003) Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence-accelerated mouse. J Lipid Res 44, 762-769
49. Doolittle MH, LeBoeuf RC, Warden CH, Bee LM and Lusis AJ (1990). A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J Biol Chem 265, 16380-16388
50. Kitagawa K, Naiki H, Takeda T and Higuchi K (1994). Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis. Lab Invest 70, 565-571